Skip to Main Content
Symposium U.S.-China Life Science Industry Collaborations
Tuesday, June 22, 2010
Online registration closes on Sunday, June 20, 2010 at 7 pm. After that it will be pay by check or credit card (Visa or Mastercard) at the door.
There will be a 30% surcharge on all tickets for pay at the door.
SO SIGN UP THIS WEEK SO WE CAN PLAN FOR YOU!!!!
June 22, 2010
Symposium: 9:00 am - 5:00 pm
Networking Reception and Banquet: 5:30 pm - 8:30 pm
Woolsey Hall, Presidents Room
The Symposium on U.S.-China Life Science Industry Collaborations is designed to introduce biotech and pharma companies to the opportunities afforded for research and development and commercialization partnering by China.
Multinational pharma companies started their China strategy in the 70s, and now have established significant manufacturing, R&D, and commercialization capabilities. Their confidence in China is highlighted by GlaxoSmithKline’s decision to move its global neuroscience R&D center to Shanghai. Smaller and early stage biotech companies have heard about the opportunities provided by Chinese CROs and CMOs, and are feeling the necessity to correctly utilize the resources in China to remain competitive. China’s robust market growth, improved R&D and outsourcing capabilities, and pipeline of novel molecules open the doors to strategic partnerships.
This one day meeting is an opportunity to get an overview of the Chinese industry landscape, hear case studies on successful relationships that have been established and get some early ideas on how to go about setting up a strategic relationship with a Chinese company.
* Leaders of the China National Center for Biotechnology Development
* Representatives from two Bioscience Parks in China
* CEO of the largest Vaccine Company in China
* Executives of the Chinese biotech and pharma companies
* Executives from China’s leading CRO
* Executives from Yale University's technology transfer office
* Connecticut Economic Development Commissioner
* CEO of CURE (Connecticut State bioscience organization)
Leaders of Connecticut biotechs
* Partner from Wiggin and Dana (Connecticut law firm)
At the meeting, we will cover:
* An overview of the Chinese Biotech Industry
* Introduction on Chinese vaccine industry and development trend
* Chinese Bioscience Parks
* Collaborations between business and academia. American and China
* Case studies
“China’s pharmaceutical market is expected to continue to grow at a 20+% pace annually (global growth at 4-7%), and contribute 21% of overall global growth through 2013. China will become the world's third-largest prescription drug market in 2011.”
Source: IMS Health
“Partnering has become a significant component of China’s burgeoning biopharma industry. The number of partnering deals grew by 41% in 2009, with co-development deals the fastest growing segment. This has been driven by China’s robust pipeline of over 2,000 novel molecules with nearly 200 in clinical development.”
Connecticut United for Research Excellence, Inc.
China National Center for Biotechnology Development (CNCBD)
Columbus Growth Partners (CGP)
Questions? Email: firstname.lastname@example.org
$50* for CURE / NYBA members / MassBio and the Yale Community.
$30* for students and postdocs (includes lunch)
* Plus service charge of $3
Networking Reception and Banquet at Yale on June 22
$100 per person
TrustWave - Trusted Commerce
Event Contact Information
Update your LinkedIn Network
Tweet this on Twitter
Share on Facebook
Copyright © 2015 Lanyon.
Your Privacy Rights